Asuka Okada

Research Field

Neuroendocrine carcinoma

Cite

Citations (0)

Primary Malignant Lymphoma Originating from the Chest Wall without Preceding Pleural Disease

Internal Medicine (2017)

Yumi Iwasa Asuka Okada Hideaki Takenaka Terukazu Takahashi Nobuo Koguchi

An 84-year-old woman presented to our hospital with dyspnea on exertion and left back pain. Chest X-ray and chest computed tomography (CT) revealed an irregular pleural mass invading her left chest wall with rib destruction and pleural effusion. CT-guided needle biopsy revealed diffuse large B-cell lymphoma. Low-dose oral etoposide produced a complete response, and she continued oral chemotherapy for one year after the diagnosis and maintained good performance status. We herein report a very rare case of non-pyothorax-associated lymphoma that nonetheless resulted in great recovery.

Pleural disease

Exertion

10.2169/internalmedicine.56.7053

Cite

Citations (6)

A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed, or Bevacizumab+Pemetrexed in Advanced Nonsquamous Non-Small Cell Lung Cancer (Kyoto Thoracic Oncology Research Group 1101)

Toshihiko Kaneda Hironori Yoshida Yuichi Sakamori Hiroki Nagai Hiroaki Ozasa

Pemetrexed

Maintenance therapy

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6189

Cite

Citations (0)

Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan

Journal of Thoracic Oncology (2022)

Makoto Hibino Kiyoaki Uryu Takayuki Takeda Yusuke Kunimatsu Shinsuke Shiotsu

Patients with cancer have been prioritized for vaccination against severe acute respiratory syndrome coronavirus 2. Nevertheless, there are limited data regarding the safety, efficacy, and risk of developing immune-related adverse events (irAEs) associated with mRNA vaccines in patients with lung cancer, especially those being actively treated with immune checkpoint inhibitors.

Interquartile range

10.1016/j.jtho.2022.05.015

Cite

Citations (17)

Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status

Targeted Oncology (2023)

Kenji Morimoto Tadaaki Yamada Hayato Kawachi Motohiro Tamiya Yoshiki Negi

Performance status

Chemoimmunotherapy

10.1007/s11523-023-01012-1

Cite

Citations (2)

Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005)

Clinical Lung Cancer (2024)

Hayato Kawachi Motohiro Tamiya Yuko Oya Go Saito Yoshihiko Taniguchi

Durvalumab

10.1016/j.cllc.2024.07.014

Cite

Citations (1)

Concomitant Systemic Sclerosis and Sarcoidosis with Combined Pulmonary Fibrosis and Emphysema

Internal Medicine (2016)

Nobuo Koguchi Asuka Okada Sumito Choh Kumiko Katayama Hideaki Takenaka

A 75-year-old woman was referred to our hospital with the chief symptom of dyspnea. Chest computed tomography revealed lymphadenopathy, emphysema, and honeycombing. Sarcoidosis was diagnosed due to an elevated serum ACE level and the findings of a lymph-node biopsy. Her smoking history, radiography findings, and impaired gas exchange indicated combined pulmonary fibrosis and emphysema (CPFE). Raynaud's phenomenon gradually appeared, and we also diagnosed her with systemic sclerosis (SSc). Right heart catheterization revealed pulmonary hypertension (PH). Smoking was assumed to be the chief cause, but SSc may also induce the development of CPFE. Severe PH induced by CPFE or SSc was present, but the influence of sarcoidosis also could not be ignored.

Honeycombing

Concomitant

Lung biopsy

10.2169/internalmedicine.55.5903

Cite

Citations (1)

[Intentional limited resection for small adenocarcinoma with ground-glass opacity component more than 50% on computed tomography].

PubMed (2004)

M Tuchida Takayuki Aoki Toru Hashimoto Hideki Shinohara Masatoshi Saitou

Fifty-eight patients who had small lung tumors 2 cm or less with ground-glass opacity (GGO) component more than 50% on high resolution computed tomography (HRCT) underwent intentional limited resection. After bronchioloalveolar carcinoma without both active fibroblastic proliferation and invasive sign to the stroma was confirmed, limited resection was completed in 50 patients. In 8 patients, procedure was converted lobectomy because of microscopic invasive sign in 4, active fibroblastic proliferation in 2, and other reasons in 2. Unexpected invasive sign was found by detailed post-operative examination in 2 cases. Five-year survival rate was 98% with a mean follow-up period of 48.8 months. A limitation of intra-operative diagnosis was revealed and the accuracy of diagnosis should be improved by not only intra-operative pathological diagnosis but also HRCT images.

Ground-glass opacity

High-resolution computed tomography

Source

Cite

Citations (4)

Impact Of Comprehensive Computed Tomography Assessment With Extracellular Volume And Longitudinal Strain Analysis On Transcatheter Aortic Valve Replacement Outcomes

Journal of cardiovascular computed tomography (2023)

Hideki Koike Stanley Schmidt Victor Cheng Miho Fukui Asuka Okada

Valve replacement

Computed Tomography Angiography

10.1016/j.jcct.2023.05.217

Cite